Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

SKF-81,297

From Wikipedia, the free encyclopedia
Synthetic drug, a stimulant
Pharmaceutical compound
SKF-81,297
Clinical data
ATC code
  • none
Identifiers
  • 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC16H16ClNO2
Molar mass289.76 g·mol−1
3D model (JSmol)
  • Clc1c(O)c(O)cc2c1CCNCC2c3ccccc3

SKF-81,297 is asyntheticdrug of thebenzazepinechemical class that acts as aselectivedopamine D1/D5 receptorfull agonist, and produces a characteristicstimulant-like pattern ofanorexia,hyperactivity andself-administration in animals.[1] This profile is shared with several related drugs such as6-Br-APB andSKF-82,958,[2] but not with certain other D1 full agonists such asA-77,636, reflectingfunctional selectivity of D1 activation.[3][4][5] Newer findings reveal that SKF-81,297 additionally acts as a partial agonist atD1-D2 receptor heteromers.[6]

One of the patented uses for SKF-81,297 is as an augmentation agent when combined with an appropriate choice of an antidepressant.[7]

See also

[edit]

References

[edit]
  1. ^Weed MR, Vanover KE, Woolverton WL (1993). "Reinforcing effect of the D1 dopamine agonist SKF 81297 in rhesus monkeys".Psychopharmacology.113 (1):51–2.doi:10.1007/BF02244333.PMID 7862828.S2CID 7292320.
  2. ^Weed MR, Paul IA, Dwoskin LP, Moore SE, Woolverton WL (October 1997). "The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys".The Journal of Pharmacology and Experimental Therapeutics.283 (1):29–38.PMID 9336305.
  3. ^Chausmer AL, Katz JL (January 2002)."Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents".Psychopharmacology.159 (2):145–53.doi:10.1007/s002130100896.PMID 11862342.S2CID 6788631.
  4. ^Graham DL, Hoppenot R, Hendryx A, Self DW (April 2007). "Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats".Psychopharmacology.191 (3):719–30.doi:10.1007/s00213-006-0473-5.PMID 16835769.S2CID 21192319.
  5. ^Delfino M, Kalisch R, Czisch M, Larramendy C, Ricatti J, Taravini IR, Trenkwalder C, Murer MG, Auer DP, Gershanik OS (September 2007)."Mapping the effects of three dopamine agonists with different dyskinetogenic potential and receptor selectivity using pharmacological functional magnetic resonance imaging".Neuropsychopharmacology.32 (9):1911–21.doi:10.1038/sj.npp.1301329.PMID 17287822.
  6. ^Rashid AJ, So CH, Kong MM, et al. (2007)."D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum".Proc. Natl. Acad. Sci. U.S.A.104 (2):654–9.Bibcode:2007PNAS..104..654R.doi:10.1073/pnas.0604049104.PMC 1766439.PMID 17194762.
  7. ^Akinori Nishi, et al. WO2012127871 (Kurume University, Nippon Medical School Foundation, Fujita Educational Inst, Rockefeller University).
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Phenethylpyrrolidines
Racetams
Psychedelics
Tropanes
Tryptamines
Others
Stimulants
Amphetamines and
phenethylamines
Adrenergic agonists
Other
Cannabinoid
antagonists
GLP-1,GIP,and / or
glucagon agonists
DACRAs
5-HT2C
receptor agonists
Absorption inhibitors
Uncouplers
Others
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists


Stub icon

Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=SKF-81,297&oldid=1316585875"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp